Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase 1/2 2Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Pancreatic Neoplasms 4Stomach Neoplasms 3Rectal Neoplasms 2Colonic Neoplasms 2Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Neutropenia 1Glioblastoma 1Gastrointestinal Neoplasms 1Diarrhea 1Colon Cancer Liver Metastasis 1Carcinoma 1

Interventions

Radiotherapy, Intensity-Modulated 3Cisplatin 3Radiotherapy 2Radiation 2Platinum 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Disulfides 2Cetuximab 21,2-diaminocyclohexaneplatinum II citrate 2(225)Ac-DOTA-c(RGDyK) 2menatetrenone 1durvalumab 1atezolizumab 1Surgical Procedures, Operative 1Specimen Handling 1Photochemotherapy 1Neck Dissection 1Irinotecan 1Gemcitabine 1Endoscopy 1Docetaxel 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Carcinoma × Irinotecan × Clear all
NCT00192712 2010-11-10

Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer

Rambam Health Care Campus

Phase 2/3 Completed
20 enrolled
Gastrointestinal

Carcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡